BioTuesdays

Author - Melane Sampson

Inventiva targeting MASH at its biological roots

Inventiva (Euronext Paris and Nasdaq: IVA) is advancing development of an oral treatment for metabolic dysfunction-associated steatohepatitis (MASH) with its investigational next-generation pan-peroxisome proliferator...

Ironwood Logo

Ironwood appoints Tammi Gaskins as CEO

Ironwood Pharmaceuticals (NASDAQ: IRWD) has announced the appointment of chief commercial officer Tammi Gaskins as CEO and a member of the board of directors, effective January 1, 2027. Current CEO Tom McCourt will...

Claritev Logo

Jennifer Main joins Claritev’s board

Claritev Corporation (NYSE: CTEV) has appointed Jennifer Main as a director of its board of directors, effective today, filling a newly created directorship on the board. Ms. Main brings more than three decades of...